ABSTRACT
AR..............................................................196 13.5.2 Contribution of the A
AR..............................................................197 13.5.3 Contribution of the A
AR............................................................199 13.5.4 Contribution of the A
AR ............................................................199 13.6 Purinergic Remodeling in Chronic Lung Disease .....................................200 13.7 Th1 vs. Th2 Cytokines, Adenosine, and Fibrosis ......................................202 13.8 Concluding Remarks...................................................................................203 Acknowledgments..................................................................................................203 References..............................................................................................................203
